abstract |
The present invention relates to novel inhibitors of neuraminidase for use as a medicament in the prophylactic or therapeutic treatment of a symptom, condition or disease caused by or associated with an infection or co-infection by a virus having neuraminidase (NA) activity, particularly of the orthomyxo- or paramyxovirus families. |